Author

N. DeVito

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Holtzhausen· 1 shared B. A. Hanks· 1 shared B. Theivanthiran· 1 shared G. Beasley· 1 shared M. P. Plebanek· 1 shared N. Yarla· 1 shared X. Wang· 1 shared Y. Xue· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Holtzhausen

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A SREBF2-dependent gene program drives an immunotolerant dendritic cell population during cancer progression

M. P. Plebanek, Y. Xue, Y.-V. Nguyen, N. DeVito, X. Wang, A. Holtzhausen, G. Beasley, N. Yarla, B. Theivanthiran, B. A. Hanks

The paper identifies SREBF2 as a regulator of mregDC development and function in the tumor microenvironment, highlighting it as a therapeutic target for immune tolerance.

bioRxiv · Apr 26, 2023 · PreprintImmunology